Applied Clinical Trials
December 01, 2019
News
28
12
The shift from paper to cloud-based regulatory information management systems (RIMS) to address operations challenges.
December 01, 2019
News
28
12
A compilation of recently released news briefs that pertain to the clinical trials industry.
December 01, 2019
News
28
12
How one biotech is tackling the unmet need for additional immunotherapies and combination approaches in cancer.
December 01, 2019
News
28
12
A new era for clinical trials supply compliance in the EU is almost here.
December 01, 2019
Feature Articles
28
12
The long-running SEND initiative has fostered new FDA-industry partnerships, opening the door to dramatic changes in toxicology data analysis.
December 01, 2019
News
28
12
Recruitment study tests the use of a ride-sharing service.
December 01, 2019
Issue PDF
28
12
Click the title above to open the Applied Clinical Trials December 2019 issue in an interactive PDF format.
December 01, 2019
From the Editor
28
12
Some thoughts around the industry continuing to grapple with the high price tag associated with drug development costs.
December 01, 2019
Feature Articles
28
12
Outlining the nation’s key changes and current requirements in processing investigational and new drug applications.
December 01, 2019
Feature Articles
28
12
Why and how FDA is funding a digital biomarkers study that centers on quality of life for patients with heart failure.
December 01, 2019
News
28
12
A view of the notable policy strategies advanced in 2019 to boost drug development and review.
December 01, 2019
News
28
12
Peter O’Donnell explores where the EU stands today in R&D pursuits for new antibacterial therapies.
December 01, 2019
A Closing Thought
28
12
The regulatory path for virtual studies is nebulous and potentially difficult to navigate-finding a way forward requires a thorough understanding of the terrain and how to apply existing legal frameworks.
December 01, 2019
28
12
Examining the unique aspects involved in preparing and submitting marketing applications for proposed treatments for rare disease.
December 01, 2019
Clinical Trial Insights
28
12
Higher screen failure and patient dropout rates are raising the imperative to pilot and implement new study conduct models in trial recruitment and retention.